Clinical trialNCT05054140UnknownPhase 2Interventional

Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis

SponsorImmunic AGEnrollment450Multiple Sclerosis

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Robert J. Fox, MD
Mellen Center for MS, Neurological Institute, Cleveland Clinic, Ohio
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

73 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Bulgaria

Mhat Pulse
Blagoevgrad, Bulgaria
Mhat"heart and Brain" Ead
Burgas, Bulgaria
Dr. Maya Danovska
Pleven, Bulgaria
Dr. Plamen Bozhinov
Pleven, Bulgaria
Umhat Pulmed
Plovdiv, Bulgaria
Dr. Rositsa Krasteva
Rousse, Bulgaria
Dr. Nikolay Georgiev
Shumen, Bulgaria
Mhat Shumen
Shumen, Bulgaria
Dr. Ivan Milanov
Sofia, Bulgaria
Dr. Kana Prinova
Sofia, Bulgaria
Dr. Kosta Kostov
Sofia, Bulgaria
Dr. Penko Shotekov
Sofia, Bulgaria
Dr. Rosen Ikonomov
Sofia, Bulgaria
Mhat Lyulin
Sofia, Bulgaria
Mhat Sveta Sofia
Sofia, Bulgaria
Umhat Alexandrovska
Sofia, Bulgaria
Umhatsm N.I.Pirogov
Sofia, Bulgaria
Umhat Prof. Stoyan Kirkovich
Stara Zagora, Bulgaria
Dr. Ara Kaprelyan
Varna, Bulgaria

Canada

Montreal Neurological Inst.
Montreal, Canada
the Ottawa Hospital Research Institute
Ottawa, Canada

Czechia

Fakultni Nemocnice
Hradec Králové, Czechia

Germany

Datamed Gmbh
Cologne, Germany
Klinik Und Poliklinik Für Neurologie, Universitätsklinikum Dresden
Dresden, Germany
Neuro Centrum Science Gmbh
Erbach im Odenwald, Germany
Universitätsklinikum Hamburg Eppendorf
Hamburg, Germany

Moldova

Dr. Mihail Gavriliuc
Chisinau, Moldova
Dr. Olesea Odainic
Chisinau, Moldova
Dr. Stanislav Groppa
Chisinau, Moldova

Netherlands

Dr. Eva Strijibis
Amsterdam, Netherlands
Alrijne Ziekenhuis
Leiderdorp, Netherlands

North Macedonia

Dr. Ana Doneva Skopje 1000
Skopje, North Macedonia
Dr. Milcho Demerdziev
Skopje, North Macedonia
Dr. Tatjana Boshkova
Skopje, North Macedonia

Poland

Dr. Robert Bonek
Bydgoszcz, Poland
Dr. Janusz Zbrojkiewicz
Katowice, Poland
Dr. Maciej Maciejowski
Katowice, Poland
Dr. Elzbieta Jasinska
Kielce, Poland
Dr. Marcin Nastaj
Lublin, Poland
Indywidualna Praktyka Lekarska Prof. Rejdak
Lublin, Poland

33 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Sept 2021
Primary completion: 7 Jan 2025
Completion: 7 Jan 2025
Last update posted: 29 Apr 2024
Registered enrollment: 450
Registry id: NCT05054140

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.